Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in GALT — Galectin Therapeutics Inc

CIK 1000275 TORONTO, A6
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,571
+$4,595 QoQ
Shares Held
1,632
+53.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 98 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. GALT ranks #306 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in GALT

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,571 1,632
2026-03-31 $2,976 1,067
2025-12-31 $25,687 6,175
2025-09-30 $2,017 476
2025-06-30 $52,608 24,933
2025-03-31 $662 544
2024-12-31 $2,376 1,843
2024-09-30 $9,847 3,581
2024-06-30 $7,991 3,536
2023-12-31 $1,774 1,069
2023-06-30 $466 324
2023-03-31 $60 29
2022-09-30 $481 296
2021-09-30 $9,700 2,500
2021-06-30 $17,270 5,397
2021-03-31 $7,299 3,364
2020-12-31 $8,018 3,580
2020-09-30 $2,274 852
2020-06-30 $3,629 1,186
2020-03-31 $23,543 12,012